Apeiron RIA LLC Has $381,000 Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Apeiron RIA LLC raised its position in Mettler-Toledo International Inc. (NYSE:MTD) by 22.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 311 shares of the medical instruments supplier’s stock after buying an additional 56 shares during the period. Apeiron RIA LLC’s holdings in Mettler-Toledo International were worth $381,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in MTD. DT Investment Partners LLC boosted its holdings in shares of Mettler-Toledo International by 13.3% in the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares in the last quarter. UMB Bank n.a. raised its position in Mettler-Toledo International by 8.0% in the 3rd quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier’s stock valued at $183,000 after purchasing an additional 9 shares during the last quarter. Suncoast Equity Management boosted its stake in Mettler-Toledo International by 2.0% in the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after purchasing an additional 9 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock worth $1,135,000 after purchasing an additional 9 shares during the last quarter. Finally, Huntington National Bank increased its stake in shares of Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on MTD shares. Wells Fargo & Company decreased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Robert W. Baird dropped their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,335.76 on Friday. The firm has a 50-day moving average of $1,245.04 and a 200-day moving average of $1,343.30. The company has a market cap of $28.18 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a one year low of $1,133.46 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.